Acquisition speculation lifts Isis Pharmaceuticals

Acquisition speculation lifted shares of Isis Pharmaceuticals Inc. (Nasdaq: ISIS) $3.89 to close at $40.01.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.